aGvHD is a major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. The patients (N=173) treated in EAP previously failed 1 to 6 aGvHD systemic treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback